Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-17-025624

VP, Finance sold 1,114 shares at $2.46 ($2,740)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Selby Brian L. VP, Finance 2017-04-03 Sale −1,114 $2.46 $2,740 1,275 D
Open-market sales · 1,114 sh · avg $2.46 · $2,740
Loading xslF345X03/doc4.xml…